Project Details
Description
An Open Label, Dose Range, Proof-of-Concept Study to Assess the Safety and Efficacy of HM15421/GC1134A in Patients with Fabry Disease
| Status | Active |
|---|---|
| Effective start/end date | 8/18/25 → 8/17/35 |
Funding
- GC BIOPHARMA
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.